Skip to main content
Top
Published in: Skeletal Radiology 6/2013

01-06-2013 | Scientific Article

Is the assessment of the central skeleton sufficient for osseous staging in breast cancer patients? A retrospective approach using bone scans

Authors: Julia Krammer, Dorothee Engel, Andreas Schnitzer, Clemens G. Kaiser, Dietmar J. Dinter, Joachim Brade, Stefan O. Schoenberg, Klaus Wasser

Published in: Skeletal Radiology | Issue 6/2013

Login to get access

Abstract

Objective

By analyzing bone scans we aimed to determine whether the assessment of the central skeleton is sufficient for osseous staging in breast cancer patients. This might be of interest for future staging modalities, especially positron emission tomography/computed tomography, usually sparing the peripheral extremities, as well as the skull.

Materials and methods

In this retrospective study, a total of 837 bone scans for initial staging or restaging of breast cancer were included. A total of 291 bone scans in 172 patients were positive for bone metastases. The localization and distribution of the metastases were re-evaluated by two readers in consensus. The extent of the central skeleton involvement was correlated to the incidence of peripheral metastases.

Results

In all 172 patients bone metastases were seen in the central skeleton (including the proximal third of humerus and femur). In 34 patients (19.8 %) peripheral metastases of the extremities (distally of the proximal third of humerus and femur) could be detected. Sixty-four patients (37.2 %) showed metastases of the skull. Summarizing the metastases of the distal extremities and skull, 79 patients (45.9 %) had peripheral metastases. None of the patients showed peripheral metastases without any affliction of the central skeleton. The incidence of peripheral metastases significantly correlated with the extent of central skeleton involvement (p < 0.001).

Conclusions

Regarding bone scans, an isolated metastatic spread to the peripheral skeleton without any manifestation in the central skeleton seems to be the exception. Thus, the assessment of the central skeleton should be sufficient in osseous breast cancer staging and restaging. However, in case of central metastases, additional imaging of the periphery should be considered for staging and restaging.
Literature
1.
go back to reference Galasko CS. Skeletal metastases and mammary cancer. Ann R Coll Surg Engl. 1972;50:3–28.PubMed Galasko CS. Skeletal metastases and mammary cancer. Ann R Coll Surg Engl. 1972;50:3–28.PubMed
2.
go back to reference Coleman RE, Rubens RD. The clinical course of bone metastases from breast cancer. Br J Cancer. 1987;55:61–6.PubMedCrossRef Coleman RE, Rubens RD. The clinical course of bone metastases from breast cancer. Br J Cancer. 1987;55:61–6.PubMedCrossRef
3.
go back to reference Coleman RE, Smith P, Rubens RD. Clinical course and prognostic factors following bone recurrence from breast cancer. Br J Cancer. 1998;77:336–40.PubMedCrossRef Coleman RE, Smith P, Rubens RD. Clinical course and prognostic factors following bone recurrence from breast cancer. Br J Cancer. 1998;77:336–40.PubMedCrossRef
4.
go back to reference Ahmed A, Glynne-Jones R, Ell PJ. Skeletal scintigraphy in carcinoma of the breast—a ten-year retrospective study of 389 patients. Nucl Med Commun. 1990;11:421–6.PubMedCrossRef Ahmed A, Glynne-Jones R, Ell PJ. Skeletal scintigraphy in carcinoma of the breast—a ten-year retrospective study of 389 patients. Nucl Med Commun. 1990;11:421–6.PubMedCrossRef
5.
go back to reference Wikenheiser KA, Silberstein EB. Bone scintigraphy screening in stage I-II breast cancer: is it cost-effective? Cleve Clin J Med. 1996;63:43–7.PubMedCrossRef Wikenheiser KA, Silberstein EB. Bone scintigraphy screening in stage I-II breast cancer: is it cost-effective? Cleve Clin J Med. 1996;63:43–7.PubMedCrossRef
6.
go back to reference Yip CH, Paramsothy M. Value of routine 99mTc-MDP bone scintigraphy in the detection of occult skeletal metastases in women with primary breast cancer. Breast. 1999;8:267–9.PubMedCrossRef Yip CH, Paramsothy M. Value of routine 99mTc-MDP bone scintigraphy in the detection of occult skeletal metastases in women with primary breast cancer. Breast. 1999;8:267–9.PubMedCrossRef
7.
go back to reference Myers RE, Johnston M, Pritchard K, et al. Baseline staging tests in primary breast cancer: a practice guideline. CMAJ. 2001;164:1439–44.PubMed Myers RE, Johnston M, Pritchard K, et al. Baseline staging tests in primary breast cancer: a practice guideline. CMAJ. 2001;164:1439–44.PubMed
8.
go back to reference Dose-Schwarz J, Mahner S, Schirrmacher S, et al. [Detection of metastases in breast cancer patients: comparison of FDG PET with chest X-ray, bone scintigraphy and ultrasound of the abdomen]. Nuklearmedizin. 2008;47:97–103 [in German].PubMed Dose-Schwarz J, Mahner S, Schirrmacher S, et al. [Detection of metastases in breast cancer patients: comparison of FDG PET with chest X-ray, bone scintigraphy and ultrasound of the abdomen]. Nuklearmedizin. 2008;47:97–103 [in German].PubMed
9.
go back to reference Taira AV, Herfkens RJ, Gambhir SS, Quon A. Detection of bone metastases: assessment of integrated FDG PET/CT imaging. Radiology. 2007;243:204–11.PubMedCrossRef Taira AV, Herfkens RJ, Gambhir SS, Quon A. Detection of bone metastases: assessment of integrated FDG PET/CT imaging. Radiology. 2007;243:204–11.PubMedCrossRef
10.
go back to reference Ghanem N, Altehoefer C, Kelly T, et al. Whole-body MRI in comparison to skeletal scintigraphy in detection of skeletal metastases in patients with solid tumors. In Vivo. 2006;20:173–82.PubMed Ghanem N, Altehoefer C, Kelly T, et al. Whole-body MRI in comparison to skeletal scintigraphy in detection of skeletal metastases in patients with solid tumors. In Vivo. 2006;20:173–82.PubMed
11.
go back to reference Hahn S, Heusner T, Kummel S, et al. Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer. Acta Radiol. 2011;52:1009–14.PubMedCrossRef Hahn S, Heusner T, Kummel S, et al. Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer. Acta Radiol. 2011;52:1009–14.PubMedCrossRef
12.
go back to reference Dose J, Bleckmann C, Bachmann S, et al. Comparison of fluorodeoxyglucose positron emission tomography and “conventional diagnostic procedures” for the detection of distant metastases in breast cancer patients. Nucl Med Commun. 2002;23:857–64.PubMedCrossRef Dose J, Bleckmann C, Bachmann S, et al. Comparison of fluorodeoxyglucose positron emission tomography and “conventional diagnostic procedures” for the detection of distant metastases in breast cancer patients. Nucl Med Commun. 2002;23:857–64.PubMedCrossRef
13.
go back to reference Liu T, Cheng T, Xu W, et al. A meta-analysis of 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with breast cancer. Skeletal Radiol. 2011;40:523–31.PubMedCrossRef Liu T, Cheng T, Xu W, et al. A meta-analysis of 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with breast cancer. Skeletal Radiol. 2011;40:523–31.PubMedCrossRef
14.
go back to reference Hamaoka T, Madewell JE, Podoloff DA, et al. Bone imaging in metastatic breast cancer. J Clin Oncol. 2004;22:2942–53.PubMedCrossRef Hamaoka T, Madewell JE, Podoloff DA, et al. Bone imaging in metastatic breast cancer. J Clin Oncol. 2004;22:2942–53.PubMedCrossRef
15.
go back to reference Costelloe CM, Rohren EM, Madewell JE, et al. Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis. Lancet Oncol. 2009;10:606–14.PubMedCrossRef Costelloe CM, Rohren EM, Madewell JE, et al. Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis. Lancet Oncol. 2009;10:606–14.PubMedCrossRef
16.
go back to reference Shie P, Cardarelli R, Brandon D, et al. Meta-analysis: comparison of F-18 fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastases in patients with breast cancer. Clin Nucl Med. 2008;33:97–101.PubMedCrossRef Shie P, Cardarelli R, Brandon D, et al. Meta-analysis: comparison of F-18 fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastases in patients with breast cancer. Clin Nucl Med. 2008;33:97–101.PubMedCrossRef
17.
go back to reference Heusner TA, Kuemmel S, Hahn S, et al. Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients. Eur J Nucl Med Mol Imaging. 2009;36:1543–50.PubMedCrossRef Heusner TA, Kuemmel S, Hahn S, et al. Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients. Eur J Nucl Med Mol Imaging. 2009;36:1543–50.PubMedCrossRef
18.
go back to reference Hausmann D, Kern C, Schroder MT, et al. [Whole-body MRI in preoperative diagnostics of breast cancer–a comparison with [corrected] staging methods according to the S 3 guidelines]. Rofo. 2011;183:1130–7 [in German].PubMedCrossRef Hausmann D, Kern C, Schroder MT, et al. [Whole-body MRI in preoperative diagnostics of breast cancer–a comparison with [corrected] staging methods according to the S 3 guidelines]. Rofo. 2011;183:1130–7 [in German].PubMedCrossRef
19.
go back to reference Du Y, Cullum I, Illidge TM, Ell PJ. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer. J Clin Oncol. 2007;25:3440–7.PubMedCrossRef Du Y, Cullum I, Illidge TM, Ell PJ. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer. J Clin Oncol. 2007;25:3440–7.PubMedCrossRef
20.
go back to reference Koolen BB, Vrancken Peeters MJ, Aukema TS, et al. 18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques. Breast Cancer Res Treat. 2012;131:117–26.PubMedCrossRef Koolen BB, Vrancken Peeters MJ, Aukema TS, et al. 18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques. Breast Cancer Res Treat. 2012;131:117–26.PubMedCrossRef
21.
go back to reference Riegger C, Herrmann J, Nagarajah J, et al. Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients. Eur J Nucl Med Mol Imaging. 2012;39(5):852–63 Riegger C, Herrmann J, Nagarajah J, et al. Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients. Eur J Nucl Med Mol Imaging. 2012;39(5):852–63
22.
go back to reference Delbeke D, Coleman RE, Guiberteau MJ, et al. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med. 2006;47:885–95.PubMed Delbeke D, Coleman RE, Guiberteau MJ, et al. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med. 2006;47:885–95.PubMed
23.
go back to reference Boxer DI, Todd CE, Coleman R, Fogelman I. Bone secondaries in breast cancer: the solitary metastasis. J Nucl Med. 1989;30:1318–20.PubMed Boxer DI, Todd CE, Coleman R, Fogelman I. Bone secondaries in breast cancer: the solitary metastasis. J Nucl Med. 1989;30:1318–20.PubMed
24.
go back to reference Koizumi M, Yoshimoto M, Kasumi F, Ogata E. Comparison between solitary and multiple skeletal metastatic lesions of breast cancer patients. Ann Oncol. 2003;14:1234–40.PubMedCrossRef Koizumi M, Yoshimoto M, Kasumi F, Ogata E. Comparison between solitary and multiple skeletal metastatic lesions of breast cancer patients. Ann Oncol. 2003;14:1234–40.PubMedCrossRef
25.
go back to reference Krasnow AZ, Hellman RS, Timins ME, et al. Diagnostic bone scanning in oncology. Semin Nucl Med. 1997;27:107–41.PubMedCrossRef Krasnow AZ, Hellman RS, Timins ME, et al. Diagnostic bone scanning in oncology. Semin Nucl Med. 1997;27:107–41.PubMedCrossRef
26.
go back to reference Kardamakis D, Vassiliou V, Chow E. Pathophysiology of bone metastases. In: Kardamakis D, Vassiliou V, Chow E, editors. Bone metastases: A translational and clinical approach: 12 (cancer metastasis - biology and treatment). chapter 4.3. Netherlands: Springer; 2009. pp. 80–5. Kardamakis D, Vassiliou V, Chow E. Pathophysiology of bone metastases. In: Kardamakis D, Vassiliou V, Chow E, editors. Bone metastases: A translational and clinical approach: 12 (cancer metastasis - biology and treatment). chapter 4.3. Netherlands: Springer; 2009. pp. 80–5.
27.
go back to reference Ribatti D, Mangialardi G, Vacca A. Stephen Paget and the ‘seed and soil’ theory of metastatic dissemination. Clin Exp Med. 2006;6:145–9.PubMedCrossRef Ribatti D, Mangialardi G, Vacca A. Stephen Paget and the ‘seed and soil’ theory of metastatic dissemination. Clin Exp Med. 2006;6:145–9.PubMedCrossRef
Metadata
Title
Is the assessment of the central skeleton sufficient for osseous staging in breast cancer patients? A retrospective approach using bone scans
Authors
Julia Krammer
Dorothee Engel
Andreas Schnitzer
Clemens G. Kaiser
Dietmar J. Dinter
Joachim Brade
Stefan O. Schoenberg
Klaus Wasser
Publication date
01-06-2013
Publisher
Springer-Verlag
Published in
Skeletal Radiology / Issue 6/2013
Print ISSN: 0364-2348
Electronic ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-012-1562-7

Other articles of this Issue 6/2013

Skeletal Radiology 6/2013 Go to the issue

Test Yourself: Question

An unusual facial enlargement